Tetracycline release from composite cryogels.
Tache, Alina Alexandra ; Stoica-Guzun, Anicuta ; Stroescu, Marta 等
1. INTRODUCTION
Polyvinyl alcohol (PVA) is a hydrophilic polymer capable of
forming, in aqueous solutions and under certain conditions, no covalent spatial networks, also known as cryogels. In other words, cryogels are
physically cross linked PVA gels prepared using a special method. This
method, called freeze-thawing method, is a relatively new one, still
being under intensively investigations concerning the freezing
temperature, duration of freezing and thawing rate, concentration of
polymers and other factors which can influence the final characteristics
of the cryogel. Regarding the efficiency, this method requires minimum
of energy and time resources, producing less residual solvent, while the
main product is easy to scale up. The freezing-thawing method consists
of repeated treatments of freezing and melting of the aqueous PVA
solutions, in a range from -20[degrees]C up to room temperature (Yang et
al., 2008).
PVA hydro gels prepared using freeze/thaw cycles have good
mechanical strength, are stable at room temperature, biocompatible,
non-toxic and free of initiators and cross-linkers. The main
disadvantages of these cryogels are their opaque appearance, limited
swelling capacity and thermal stability. In order to improve the PVA
cryogels' properties, they are often combined with other polymers
like poly (acrylic) acid or even with inorganic materials like
hydroxyapatite.
The PVA cryogels or PVA composites cryogels have many biomedical
applications as matrices for cell immobilization and for controlled
release of drugs (Lozinsky et al., 2003; Nugent et al., 2007). The
hydrophilic nature of the cryogel makes it different from the
non-hydrophilic matrices regarding the release of the encapsulated
component. The most common drug tested for controlled release is
insulin.
The aim of this paper is to present experimental data concerning
drug release from PVA cryogels and PVA-bacterial cellulose (BC)
composites cryogels. Tetracycline was used as the model drug.
2. PREPARATION OF CRYOGELS
In the process of obtaining the cryogels, an aqueous solution of
PVA (10% w/w) has been used, together with tetracycline solution of
different concentrations and wet biocellulose fibrils (5.5% w/w). The
polymer's molecular weight was 60 kDa and the saponification value
was 98-99%. The culture medium used to obtain BC microfibrils in an air
lift reactor was a modified Hestrin & Schramn (MHS) medium, composed
of 2.0% (w/v) glucose, 0.6% (w/v) yeast extract, 0.8% (v/v) lactate,
0.27%(w/v) [Na.sub.2]HP[O.sub.4] and 0.115% (w/v) citric acid. After 7
days, the obtained microfibrils were purified by boiling them in a 0.5 M
aqueous solution of NaOH for 30 minutes. Afterwards, the BC microfibrils
were washed several times with deionized water until neutral pH of
water.
[FIGURE 1 OMITTED]
The aqueous solutions of PVA and different contents of tetracycline
and BC were poured into cylindrical moulds.
The cryogels were obtained using three freeze-thawing cycles. Each
cycle involved lowering the temperature to -20[degrees]C and maintaining
it for 6 hours. Then, the temperature was raised to 25[degrees]C. Each
freeze-thawing cycle lasted 12 hours.
Two types of cryogels were made. One is made from PVA and
tetracycline (1) and another was obtained from PVA, BC and tetracycline
(2). The resultant cryogels used in this work have a cylindrical form,
with 14 mm in diameter. Cylinders of different heights were sliced from
these cryogels and subsequently studied for drug release. Figure 1
presents some photographs of PVA cryogels used in this work.
3. IN VITRO RELEASE STUDY
In vitro release studies were performed in a vessel under magnetic
stirring. A certain quantity of cryogel cylinders having approximately
the same height was contacted with a known volume of demineralised water
(same ratio solid/liquid).
The tetracycline content was analyzed in the liquid phase at 365 nm
using an UV-VIS spectrophotometer CENTRA 6 GBS-Scientific (Australia).
4. EXPERIMENTAL DATA ANALYSIS
The released data was analyzed by applying several release models
proposed in literature. The most common mechanism of drug release from
cryogels is passive diffusion, but the mechanism of release from
cryogels can be classified in: diffusion-controlled, swelling-controlled
and chemically-controlled. Diffusion-controlled mechanism is dependent
on the mesh sizes within the matrix of the gel; in the case of
swelling-controlled mechanism, swelling is considered to be the
controlling step for the release behaviour. The chemically-controlled
release is determined by chemical reactions occurring within the matrix
gel (Hamidi et al., 2008).
To describe the diffusional transport of the drug the following
premises were used: at the surface of the dosage the drug concentration
is constant; the release of the drug follows a first order kinetics (the
release rate is proportional to its concentration); diffusion is
isotropic (it does not depend on the spatial direction); the convective
process is insignificant, thus it can be neglected; the release of the
drug from the cylinders occurs only in axial direction (Siepmann et al.,
2006). The model is based on Fick's second law of diffusion
(considering only one dimension):
dc/dt = D x ([[partial derivative].sup.2]c/[partial
derivative][x.sup.2]]) - kc (1)
where: c--concentration of drug in the cryogel; t--time;
D--diffusion coefficient; x--spatial coordinate; k--first order rate
constant.
The following initial conditions were used: c=0 for t=0, x [greater
than or equal to] a; c = [c.sub.o] for t > 0, x = a and c = 0 for t
> 0, x [right arrow] [infinity]; where a--half of the cylinder width
and [c.sub.o]--drug concentration at the surface of the cylinder.
Considering non-steady state conditions (drug concentration
variation with time and position), the following solution for the
differential equation (1) can be derived:
[MATHEMATICAL EXPRESSION NOT REPRODUCIBLE IN ASCII] (2)
The drug concentration on the axial direction of the cylindrical
form can be calculated using equation (2).
5. RESULTS AND DISCUSSIONS
Figure 2 presents tetracycline release for four cryogels with
different compositions and different heights. All curves present an
initial burst for the first two hours.
To analyze tetracycline release equation 2 was used. From our
simulations, parameter k does not influence the results, and it was
considered [10.sup.-5] m/s in all experiments. Thus, the only variable
parameter remaining is the diffusion coefficient. Two diffusion
coefficients were calculated, each for the two types of cryogel:
[D.sub.(1)] = 0.95 x [10.sup.-9] [m.sup.2]/s for cryogels containing PVA
and tetracycline and [D.sub.(2)] = 1.00 x [10.sup.-9] [m.sup.2]/s for
the cryogels containing PVA-BC and tetracycline.
The experimental results and theoretical curves are presented in
figure 3 for the cryogels having 5 mm height. A good agreement can be
observed between experimental and predicted values obtained from
equation (2).
Relatively higher values of the diffusion coefficients proove that
the diffusion occurs mainly through the water phase. These values were
obtained for cylinders with H < 5 mm, where H is the cylinder height.
For cylinders with higher values of H, the agreement between theory and
experiment is not conclusive. One possible explanation could be a
swelling-controlled mechanism and even an erosion mechanism which were
not taken into account in the proposed model.
[FIGURE 2 OMITTED]
[FIGURE 3 OMITTED]
6. CONCLUSIONS
An experimental study of tetracycline release from cryogels is
presented. Two cryogel types were used, one containing only PVA and
teracycline and the other, a composite one, containing also bacterial
cellulose. A simple diffusion model was used to obtain diffusion
coefficients of tetracycline from these cryogels in water. The values
obtained only for the cryogels with the height smaller than 5 mm are
relatively high and very close to the tetracycline diffusion coefficient
in water (D = 3.83 x [10.sup.-9] [m.sup.2]/s). These values can be
explained by the fact that the diffusion occurs mainly through the water
which is contained in cryogels and which can also migrate from the
continuous external phase.
There were no significant differences between the values of
diffusion coefficients for the cryogels containing only PVA and
tetracycline and those containing also bacterial cellulose. Further
experiments indicated that bacterial cellulose has the potentioal to
enhance mechanical and chemical resistance of cryogels. Nevertheless,
more experiments are necessary to elucidate the interactions between
polyvinyl alcohol and bacterial cellulose in composite cryogels.
The authors express their acknowledgements to the CNCSIS grants
committee, as part of this research has been supported by the IDEI program, project code ID_1031, contract number 177/2007.
7. REFERENCES
Hamidi, M., Azadi, A., Rafiei, P., Hydrogel nanoparticles in drug
delivery, Advanced Drug Delivery Reviews (2008), 60, 1638-1649
Lozinsky, V. I., Galaev, I. Yu., Plieva, F. M., Savina, I. N.,
Jungvid, H., Mattiasson, B., Polymeric cryogels as promising materials
of biotechnological interest, Trends in Biotechnology (2003), 32,
445-451
Nugent, M., Higginbotham, C. L., Preparation of a novel freeze
thawed poly (vinyl alcohol) composite hydrogel for drug delivery
applications, European Journal of Pharmaceutics and Biopharmaceutics
(2007), 67, 377-386
Siepmann, J., Siepmann, F., Florence, A.T., Local controlled drug
delivery to the brain: Mathematical modeling of the underlying mass
transport mechanisms, Review, International Journal of Pharmaceutics
(2006), 314, 101-119
Yang, X., Liu, Q., Chen, X., Yu, F., Zhu, Z., Investigation of
PVA/ws-chitosan hydrogels prepared by combination [gamma]-irradiation
and freeze-thawing, Carbohydrates Polymers (2008), 73, 410-408